Morse CyberKnife Company Profile

14:53 EDT 25th September 2017 | BioPortfolio

News Articles [34 Associated News Articles listed on BioPortfolio]

BLK Cyberknife Center to Promote Spine Tumors Treatment with Radio Surgery

New Delhi, India, July 02, 2017 --( BLK Cyberknife Center Announces Spine Tumors treatment with radiosurgery, although treating spinal tumors can be really challenging because they can move ...

Neuro Spinal Hospital In Dubai To Acquire Accuray Inc. CyberKnife And Radixact Systems

  Life Sciences Jobs   ...

Genomic Vision Extends its Patent Portfolio With the Genomic Morse Code

PARIS, July 3, 2012 /PRNewswire/ -- Genomic Vision, a leading biotechnology company specializing in developing genetic diagnostic tests using DNA molecular combing, is announcing the extension of its...

Accuray Inc. Release: New Data Presented At Reinforce Unmatched Versatility And Precision Of The CyberKnife System

  Life Sciences Jobs   ...

Accuray Inc. Release: Anova Marks 1,500th Prostate Cancer Patient Treated with the Accuray CyberKnife System

  Life Sciences Jobs   ...

The run to recovery: How the Minnesota Adult & Teen Challenge promotes sobriety

Andy Steiner It wasn’t the first time Kevin Joyce had gone running, but for some reason the first time he laced up his shoes and went out for...

Russia Radiosurgery Market Outlook to 2023 [Updated: 08062017] Prices from USD $4995

Russia Radiosurgery Market Outlook to 2023SummaryGlobalData's new report, "Russia Radiosurgery Market Outlook to 2023", provides key market data on the Russia Radiosurgery market. The report provides ...

Canada Radiosurgery Market Outlook to 2023 [Updated: 08062017] Prices from USD $4995

Canada Radiosurgery Market Outlook to 2023SummaryGlobalData's new report, "Canada Radiosurgery Market Outlook to 2023", provides key market data on the Canada Radiosurgery market. The report provides ...

Drugs and Medications [0 Results]


PubMed Articles [30 Associated PubMed Articles listed on BioPortfolio]

Robotic radiosurgery of head and neck paragangliomas: a single institution experience.

CyberKnife(®) is a robotic stereotactic radiotherapy system. The aim of this study is to evaluate the effectiveness and the safety of CyberKnife(®) on treating head and neck paragangliomas and to re...

Evaluation of Clinical Application and Dosimetric Comparison of Treatment Plans of Gamma Knife and CyberKnife in Treating Arteriovenous Malformations.

To analyze and compare the characteristics of dose distributions for Leksell Gamma Knife Perfexion (LGK-PFX) and CyberKnife (CK) in treating arteriovenous malformations (AVMs).

Morse Taper Implants Immediately Loaded in Fresh Extraction Sockets: A Prospective Cohort Study.

To evaluate survival rate and bone response around immediate loaded Morse taper implants installed in fresh sockets on the anterior area of the maxilla.

Analysis of risk prediction capability and validity of Morse Fall Scale Brazilian version.

To analyse the power to predict risk and verify the validity of the Morse Fall Scale - Brazilian version (MFS-B).

Tactile Morse Code Using Locational Stimulus Identification.

This research investigated several haptic interfaces designed to reduce mistakes in Morse code reception. Results concluded that a bimanual setup, discriminating dots/dashes by left/right location, re...

Clinical Trials [36 Associated Clinical Trials listed on BioPortfolio]

CyberKnife for Unresectable Renal Tumors

This is a dose escalation study using the CyberKnife radiotherapy device for small surgical or medically untreatable renal tumors. Patients with renal tumors 5cms or less in diameter will ...

CyberKnife Radiosurgery for Localized Prostatic Carcinoma

Virtual high dose rate (HDR) CyberKnife (CK) prostate treatment has comparable morbidity and efficacy compared with actual prostate HDR treatment, but does it without the catheters and hos...

Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002)

This study is looking at determining the maximum safe dose of CyberKnife when given with chemotherapy for unresectable adenocarcinoma of the pancreas.

CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry

The purpose of this study is to investigate the effects of CyberKnife radiosurgery in patients with early stage organ-confined prostate cancer and to evaluate the effects of this treatment...

A Pilot Study of CyberKnife Radiosurgery Delivered to the Partial Breast

This pilot study will evaluate the technical feasibility and acute toxicity of Partial Breast Irradiation (PBI) with the CyberKnife in anticipation of a larger multi-institutional Phase II...

Companies [13 Associated Companies listed on BioPortfolio]

Morse CyberKnife

Fairbanks Morse Engine

Fairbanks Morse is a worldwide leader in diesel and dual-fuel engine technology and manufacturing. The company’s mission is to provide the highest quality diesel and dual-fue...


Accuray's history began when John R. Adler, MD, professor of neurosurgery and radiation oncology at Stanford University Medical Center, developed the CyberKnife® System in 1987 after completing a fel...

Morse LLC

Accuray Incorporated

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option ...

More Information about "Morse CyberKnife" on BioPortfolio

We have published hundreds of Morse CyberKnife news stories on BioPortfolio along with dozens of Morse CyberKnife Clinical Trials and PubMed Articles about Morse CyberKnife for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Morse CyberKnife Companies in our database. You can also find out about relevant Morse CyberKnife Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record